20
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Biological Implications of Circulating Soluble Intercellular Adhesion Molecule-1 in Colorectal Cancer Patients

Pages 399-404 | Published online: 08 Jul 2009

References

  • Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4–17.
  • Ponta H, Sleeman J, Herrlich P. Tumor metastasis formation: cell-surface proteins confer metastasis-promoting or -suppressing properties. Biochim Biophys Acta 1994;1198:1–10.
  • Banner BF, Savas L, Woda BA. Expression of adhesion molecules in the host response to colon carcinoma. Ultrastruct Pathol 1995;19:113–8.
  • Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, et al. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998; 77:1857–63.
  • Agrez MV. Cell adhesion molecules and colon cancer. Aust NZ J Surg 1996;66:791–8.
  • Maurer CA, Friess H, Kretschmann B, Wildi S, Muller C, Graber H, et al. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer 1998;79:76–81.
  • Mulder WM, Stern PL, Stukart MJ, de Windt E, Butzelaar RM, Meijer S, et al. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. Clin Cancer Res 1997;3: 1923–30.
  • Rokhlin OW, Cohen MB. Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Lett 1996;107:29–35.
  • De Vita F, Infusino S, Auriemma A, Orditura M, Catalano G. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients. Oncol Rep 1998;5: 393–6.
  • Yoo NC, Chung HC, Chung HC, Park JO, Rha SY, Kim JH, et al. Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression. Yonsei Med J 1998;39:27–36.
  • Regidor PA, Callies R, Regidor M, Schindler AE. Expression of the cell adhesion molecules ICAM-1 and VCAM-1 in the cytosol of breast cancer tissue, benign breast tissue and corresponding sera. Eur J Gynaecol Oncol 1998;19:377–83.
  • De Vita F, Infusino S, Auriemma A, Orditura M, Catalano G. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients. Oncol Rep 1998;5: 393–6.
  • Benekli M, Gullu IH, Tekuzman G, Savas MC, Hayran M, Hascelik G, et al. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. Br J Cancer 1998;78: 267–71.
  • Friess H, Yamanaka Y, Büchler MW, Ebert M, Beger HG, Gold LI, et al. Enhanced expression of transforming growth factor-beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846–56.
  • Koyama S, Ebihara T, Fukao K. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 1992;118: 609–14.
  • Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990;15;50:1271–8.
  • Torii A, Harada A, Nakao A, Nonami T, Ito M, Takagi H. Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol 1993;53:239–42.
  • Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Buschenfelde KH. Expression of intercellular adhesion molecule 1(ICAM-1, CD54) in colonic epithelial cells. Gut 1993;34: 1593–7.
  • Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R, Aranda E. Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxity. Eur J Cancer 1998;34: 394–8.
  • Grothey A, Heistermann P, Philippou S, Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumor stage. Br J Cancer 1998;77: 801–7.
  • Sprenger A, Schardt C, Rotsch M, Zehrer M, Wolf M, Havemann K, et al. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. J Cancer Res Clin 1997;123:632–8.
  • Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506–12
  • Lim AG, Wolfhagen HJ, Verma A, van Buuren HR, Jazrawi RP, Levy JH, et al. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. Eur J Gastroenterol Hepatol 1997; 9:145–7.
  • Burno DK, Kyprianou N, Sartor WN, Fabian DF, Turner J, Vu T, et al. Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy. Surgery 1995;118:237–43.
  • Sartor WN, Kyprianou N, Fabian DF, Lefor AT. Enhanced expression of ICAM-1 in s murine fibrosarcoma reduced tumor growth rate. J Surg Res 1995;59:66–74.
  • Mizuno M, Yoshida J, Takaoka T, Sugita K. Reinforced cytotoxity of LAK cells toward glioma cells by transfection of the killer cells with the gamma interferon gene. Jpn J Cancer Res 1995;86:95–100.
  • Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H. Induction of ICAM-1 on SCLC cell lines by gamma-IFN enhances spontaneous and biospecific anti-CD3 antitumor directed LAK cell cytotoxity. Cancer Res 1992;52: 4890–4.
  • Kaihara A, Iwagaki H, Gouchi A, Hizuta A, Isozaki H, Takakura N, et al. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients. Res Commun Mol Path 1998;100:283–300.
  • Yoong KF, McNab G, Hubscher SG, Adams DH. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol 1998;160:3978–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.